APPLICATION
NDA205555
TYPE
NDA
ORIGINAL APPROVAL
2017-05-01
LATEST ACTION
2025-06-10
ROUTE
INTRAPLEURAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
STERITALC · ReferencePrescription
TALC 4GM/VIAL · POWDER · INTRAPLEURAL
STERITALC · ReferencePrescription
TALC 2GM/VIAL · POWDER · INTRAPLEURAL
STERITALC · ReferencePrescription
TALC 3GM/VIAL · POWDER · INTRAPLEURAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.